Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML

Clinical trial NCT06451861 · RECRUITING

Trial details

NCT number: NCT06451861
Sponsor: Guangdong Provincial People's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2024-08-21
Primary completion: 2026-12-30
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.